APP and Alzheimer disease: We also show that mice that are both transgenic for APP, and hemizygous for sod2, incur a higher level of tau phosphorylation, higher amyloid burden and decreased copper, zinc and manganese levels, consistent with a synergistic interaction between APP and mitochondrial oxidative stress in contributing to AD-like neocortical pathology.